EQT finds ‘perfect fit’ for new strategy with Mabtech acquisition

The private equity firm aims to grow the Swedish biotech company’s footprint in the US, partner Isabel de Paoli told PE Hub Europe.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this